Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Stock
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
11.1M
-
Shares change
-
-1.72M
-
Total reported value, excl. options
-
$11.4M
-
Value change
-
-$2.2M
-
Put/Call ratio
-
0.29
-
Number of buys
-
18
-
Number of sells
-
-29
-
Price
-
$1.02
Significant Holders of VYNE THERAPEUTICS INC COM - Stock (VYNE) as of Q4 2021
62 filings reported holding VYNE - VYNE THERAPEUTICS INC COM - Stock as of Q4 2021.
VYNE THERAPEUTICS INC COM - Stock (VYNE) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.1M shares
.
Largest 10 shareholders include DSC Advisors, L.P. (2.55M shares), VANGUARD GROUP INC (2.25M shares), PERCEPTIVE ADVISORS LLC (2.18M shares), RENAISSANCE TECHNOLOGIES LLC (905K shares), STATE STREET CORP (544K shares), GEODE CAPITAL MANAGEMENT, LLC (470K shares), MILLENNIUM MANAGEMENT LLC (431K shares), GSA CAPITAL PARTNERS LLP (218K shares), Virtu Financial LLC (175K shares), and MARSHALL WACE, LLP (165K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.